Parametric Portfolio Associates’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Parametric Portfolio Associates’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$847K	Buy	+13,664	New	+$836K	﹤0.01%	2853
2021 Q3	–	Sell	-19,510	Closed	-$1.34M	–	3626
2021 Q2	$1.34M	Sell	19,510 -9,289	-32%	-$708K	﹤0.01%	2644
2021 Q1	$2.22M	Buy	28,799 +6,306	+28%	+$581K	﹤0.01%	2714
2020 Q4	$2.23M	Buy	22,493 +10,770	+92%	+$1.32M	﹤0.01%	2593
2020 Q3	$1.66M	Sell	11,723 -6,909	-37%	-$1.15M	﹤0.01%	2621
2020 Q2	$3.68M	Buy	18,632 +6,773	+57%	+$1.4M	﹤0.01%	2100
2020 Q1	$2.32M	Buy	+11,859	New	+$2.55M	﹤0.01%	2279

Other funds holding LKFT

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Parametric Portfolio Associates's LKFT Position: Q1 2022 in Review

Parametric Portfolio Associates opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2022: 13,664 shares worth $847K. The stake represents ﹤0.01% of the portfolio and ranks #2853 among its holdings. This is a return to the name: Parametric Portfolio Associates previously reported a position in LKFT as recently as Q2 2021.

Parametric Portfolio Associates first reported a position in LKFT in Q1 2020 and has held it in 7 quarters since. The position peaked at $3.68M in Q2 2020. 89 funds tracked by Wall St. Rank hold LKFT as of Q1 2022.

Parametric Portfolio Associates held 13,664 shares of Lakefront Biotherapeutics American Depositary Shares worth $847K as of Q1 2022.
Lakefront Biotherapeutics American Depositary Shares was a new Parametric Portfolio Associates position in Q1 2022.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2853 holding.
Parametric Portfolio Associates first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2020 and has held it in 7 quarters since.
Parametric Portfolio Associates's Lakefront Biotherapeutics American Depositary Shares position peaked at $3.68M in Q2 2020.
89 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.